Prospects for Moxidectin as a New Oral Treatment for Human Scabies.
Main Authors: | Kate E Mounsey, Charlotte Bernigaud, Olivier Chosidow, James S McCarthy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-03-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4795782?pdf=render |
Similar Items
-
Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.
by: Charlotte Bernigaud, et al.
Published: (2016-10-01) -
The Management of Scabies in the 21st Century: Past, Advances and Potentials
by: Charlotte Bernigaud, et al.
Published: (2020-04-01) -
Scabies-infested pregnant women: A critical therapeutic challenge.
by: Amandine Weill, et al.
Published: (2021-01-01) -
Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies.
by: Daniel Engelman, et al.
Published: (2013-01-01) -
A tractable experimental model for study of human and animal scabies.
by: Kate Mounsey, et al.
Published: (2010-01-01)